Bakeridesia gaumeri is an endemic plant of the Yucatan peninsula, where it is used in traditional medicine for the treatment of dysentery, enterocolitis and diarrhea. The stem extract of the plant showed significant antioxidant activity in the DPPH free radical scavenging assay. Bioassay-guided fractionation of the crude extract resulted in the isolation and identification of 7-hydroxycadalenal (1, EC 50 0.85 ± 0.06 mM) and trans-clovamide (2, EC 50 0.15 ± 0.01 mM) as the metabolites responsible for the antioxidant activity of the crude extract.
The antioxidant activity is one of the most important activities of natural products; antioxidants delay or prevent oxidation of proteins, lipids, carbohydrates and DNA, and contribute to the prevention of diseases such as cancer, atherosclerosis, heart disease, and diabetes, as well as neurodegenerative disorders such as Alzheimer's and Parkinson's. Investigations of the antioxidant properties of medicinal plants have shown that natural antioxidants, either as plant crude extracts or pure bioactive components, are very effective in preventing the destructive effects caused by oxidative stress [1, 2] . These investigations, which have resulted in the identification of a wide variety of naturally occurring antioxidants with different chemical structures, as well as physical and chemical properties, and mechanism and sites of action [3] , have resulted in an increased interest for the isolation and identification of antioxidant metabolites from novel sources [4] .
Bakeridesia gaumeri (Standl.) D.M.Bates (Malvaceae), is a plant endemic to the Yucatan peninsula where it is commonly known as "Hool", "K'an hool", "Ya'ax holche", and "Ya'ax misib", and used in Mayan traditional medicine to treat dysentery, enterocolitis and diarrhea Although it has been reported that extracts of this plant have antioxidant and antimycobacterial activities [5] , to date there are no reports about its phytochemistry or the nature of the metabolites responsible for its medicinal properties. As part of our search for novel antioxidant natural products from the Yucatecan native flora, we report herein on the isolation and identification of the two major antioxidant metabolites present in the stem extract of B. gaumeri. Bioassay-guided fractionation of the stem extract of B. gaumeri yielded fractions of low and medium-polarity, each showing a major component with antioxidant activity in their chromatographic profiles, when tested using the DPPH radical reduction assay. Successive bioassay-guided chromatographic purifications of these two fractions resulted in the isolation of the known metabolites 7-hydroxycadalenal (1) [6-8] and transclovamide (2) [9] [10] [11] (Figure 1 ) from the fractions of low and medium-polarity, respectively. The identification was confirmed by comparing the spectroscopic data of the isolated metabolites with those reported in the literature. The moderate antioxidant activity (EC 50 = 0.85 ± 0.06 mM) of 7hydroxycadalenal (1), when compared to that of the ascorbic acid (positive control, EC 50 = 0.28 ± 0.02 mM), and its presence as a minor component in both the crude extract and the low polarity fraction, suggests that the contribution of this metabolite to the antioxidant activity of the stem crude extract is limited. However, the strong antioxidant activity of trans-clovamide (2) (EC 50 = 0.15 ± 0.01 mM), which is similar to that reported for rosmarinic acid (EC 50 = 0.15 mM) [12] , and the fact that this metabolite is the major bioactive component in both the crude extract and the medium polarity fraction, suggests that 2 contributes to a great extent to the strong antioxidant activity of the stem crude extract. These results are in agreement with reports of 2 being the most active polyphenol isolated from Theobroma cacao, when tested for antioxidant activity in the linoleic acid oxidation, erythrocyte ghost system, and microsomal lipid peroxidation assays [13] . This is the first report about the isolation and identification of 7hydroxycadalenal (1) and trans-clovamide (2) from B. gaumeri, and the first report on the antioxidant activity of 7-hydroxycadalenal (1). acid (5%) and 0.2% DPPH in methanol were used as universal and antioxidant-selective TLC staining solutions, respectively. IR spectra were recorded using an FT-IR Nicolet Magna Protégé 460 instrument, using CHCl 3 as solvent. 1 H-NMR and 13 C-NMR spectra were recorded on a Varian Unity-300, a Bruker AMX-400, or a Varian Unity Plus-500 spectrometer using CDCl 3 or CD 3 OD as solvents. GC-MS analyses were carried out on an Agilent Technologies 6890 N gas chromatographer coupled to a 5975B mass selective detector. ESI-MS spectra were obtained on a JEOL JMS-HX 300 mass spectrometer. Similarly, a portion (10 g) of the medium polarity fraction (B) was fractionated by VLC using a gradient elution with Hx/Acetone/MeOH mixtures to produce fractions 5A-H. Ascorbic acid was used as positive control.
DPPH radical reduction assay (Quantitative analysis):
A fresh 0.1 mM ethanolic solution of DPPH was prepared and kept away from the light. Similarly, a stock 1 mg/mL ethanolic solution of each sample and ascorbic acid (positive control) was prepared. Successive 1:10 dilutions of 100 µL of the stock solution with ethanol gave the corresponding 10 -1 , 10 -2 , 10 -3 and 10 -4 mg/mL sample solutions. 200 µL aliquots of each sample solution were combined with 1.8 mL of the DPPH solution and kept in the dark, at room temperature, for 30 minutes. The absorbance was then measured at 517 nm using a spectrophotometer; measurements were carried out in triplicate. The % of remaining DPPH radical for each sample solution was calculated by using the formula: (1 -As/Ab)*100, where As and Ab are the absorbance of the sample and the blank, respectively. The DPPH radical scavenging activity was expressed as EC 50, i.e. the amount of antioxidant necessary to decrease the initial DPPH radical concentration by 50%.
